Session: Poster Session B Abstract title:Combination immunotherapy with an albumin-binding interleukin-12 fusion protein that extends cytokine half-life, targets the tumor microenvironment, and ...

CONTINUED... Read this and more news for Oncolytics Biotech at: In other recent industry developments and happenings in the m ...

Representative Jake Auchincloss discusses how the Democratic Party can offer meaningful alternatives to voters.

NetraMark Holdings Inc. (the "Company" or "NetraMark")  a generative AI software leader in clinical trial analytics, announces that it will present new data supporting its mathematically augmented ...

AVEO Oncology, an LG Chem company ("AVEO"), is a biopharmaceutical company that is trying to provide differentiated solutions to improve cancer patients lives, presented two posters during the ...

Amity University Madhya Pradesh hosted its Convocation Ceremony for its class of 2024 in a grand and dignified atmosphere, on ...

Stoke Therapeutics Inc. (Nasdaq: STOK) has pulled in Biogen (Nasdaq: BIIB) to help it develop and commercialize a treatment ...

Though most biopharma investment is in two states, follow this model to bring the research—and investments—elsewhere.

USA News Group News Commentary – Despite optimism coming from the launch of Project Stargate (a $500 billion investment in AI ...

Market OverviewThe Global Contract Research Organization Market was valued at USD 69.25 Billion in 2022 and is projected to ...

JuliaHub is doubling its investment in the pharmaceutical sector, leveraging JuliaHub’s new-and-improved… accelant, a leader in sales, marketing, and revenue operations, is thrilled to announc ...

Through immersive and realistic simulations, the metaverse may soon open up global experiences, unlock innovative business ...